# Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation

> **NCT02702427** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **St. Anna Kinderkrebsforschung**

## Conditions studied

- Cytomegalovirus Infection
- Adenovirus Infection

## Interventions

- **BIOLOGICAL:** virus-specific T-Cells

## Key facts

- **NCT ID:** NCT02702427
- **Lead sponsor:** St. Anna Kinderkrebsforschung
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08-03
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unsuccessful recruitment
- **Last updated:** 2019-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02702427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02702427, "Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02702427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*